Treatment with propofol: The new status quo for status epilepticus?

Neurology

Volumn 65, Issue 4, 2005, Pages 506-507

  Schor, Nina F ^a   Riviello Jr , James J ^b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; FOSPHENYTOIN SODIUM; MIDAZOLAM; PENTOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; TOPIRAMATE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EPILEPTIC STATE; HEMODYNAMICS; HUMAN; INFUSION; META ANALYSIS; METABOLIC ACIDOSIS; MORTALITY; PRIORITY JOURNAL; SHOCK;

EID: 23844489805     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000173427.22021.9d     Document Type: Editorial

References (17)

1. Rossetti AO, Reichhart MD, Schaller M-D, Despland P-A, Bogousslavsky, J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004;45:757-763.
2. Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002;59:1249-1251.
3. Appleton R, Choonara I, Martland T, Phillips B, Scott R, Whitehouse W. The treatment of convulsive status epilepticus in children. Arch Dis Child 2000;83:415-419.
4. De Negri M, Baglietto MG. Treatment of status epilepticus in children. Paediatr Drugs 2001;3:411-420.
5. Mitchell WG. Status epilepticus and acute serial seizures in children. J Child Neurol 2002;17 Suppl 1:336-43.
6. Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003;44:1353-1356.
7. van Gestel JPJ, Blussé van Oud-Alblas HJ, Malingré M, Ververs FFT, Braun KPJ, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65:591-592.
8. Stecker MM, Kramer TH, Raps EC, O'Meeghan, R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
9. Prasad A, Worrall BB, Betram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001;42:380-386.
10. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146-153.
11. Hirsch NP, Smith M. Review of the evidence for the use of propofol in the management of status epilepticus. J Neurol 2003;250:1241-.
12. Sahin M, Menache C, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia 2001;42:1461-1467.
13. Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of acute symptomatic refractory status epilepticus in children. Neurology 2003;61: 398-401.
14. Parke TJ, Stevens JE, Rice ASC, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613-616.
15. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50:301-303.
16. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-1425.
17. Cornfield DN, Tegtmeyer K, Nelson MD, et al. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002;110:1177-1181.